DG Capital Management (Massachusetts)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-21,198
Closed -$1.63M 70
2015
Q4
$1.63M Sell
21,198
-24,346
-53% -$1.93M 1.46% 29
2015
Q3
$3.75M Sell
45,544
-296
-0.6% -$26.3K 2.53% 9
2015
Q2
$4.04M Sell
45,840
-2,427
-5% -$223K 2.43% 11
2015
Q1
$4.26M Sell
48,267
-2,902
-6% -$257K 2.57% 5
2014
Q4
$4.25M Sell
51,169
-2,421
-5% -$201K 2.46% 6
2014
Q3
$4.52M Buy
53,590
+6,489
+14% +$525K 2.76% 5
2014
Q2
$3.82M Sell
47,101
-12,599
-21% -$991K 2.18% 9
2014
Q1
$4.55M Sell
59,700
-3,036
-5% -$221K 2.69% 6
2013
Q4
$4.52M Buy
62,736
+9,084
+17% +$631K 2.52% 7
2013
Q3
$3.69M Sell
53,652
-9,497
-15% -$628K 2.09% 24
2013
Q2
$4M Buy
+63,149
New +$4.11M 2.43% 10

Other funds holding NVS

DG Capital Management (Massachusetts)'s NVS Position: Q1 2016 in Review

DG Capital Management (Massachusetts) sold out of Novartis (NVS) in Q1 2016, closing a stake of 21,198 shares — an estimated $1.63M sold.

DG Capital Management (Massachusetts) first reported a position in NVS in Q2 2013 and held it in 11 quarters. The position peaked at $4.55M in Q1 2014. 875 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

  • DG Capital Management (Massachusetts) reported no remaining Novartis position as of Q1 2016 after selling out during the quarter.
  • DG Capital Management (Massachusetts) sold 21,198 Novartis shares in Q1 2016, an estimated $1.63M.
  • DG Capital Management (Massachusetts) first reported a position in Novartis in Q2 2013 and held it in 11 quarters.
  • DG Capital Management (Massachusetts)'s Novartis position peaked at $4.55M in Q1 2014.
  • 875 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q1 2016, filed 11 May 2016.